SCHEMBL3479743

SCHEMBL3479743

CN1CCN(c2cc(F)cc(F)c2)c2ccc(F)cc2C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
SCN9A Q15858 1/20 0.38
HTR3E A5X5Y0 1/20 0.38
HTR3B O95264 1/20 0.38
HTR3A P46098 1/20 0.38
HTR3D Q70Z44 1/20 0.38
HTR3C Q8WXA8 1/20 0.38
NOTUM Q6P988 1/20 0.37
SLC6A2 P23975 3/20 0.37
SLC6A4 P31645 3/20 0.37
SLC6A3 Q01959 1/20 0.37
KCNQ2 O43526 1/20 0.36
HRH4 Q9H3N8 2/20 0.36
ROCK1 Q13464 1/20 0.35
MEN1 O00255 1/20 0.35
BLM P54132 1/20 0.35
KMT2A Q03164 1/20 0.35
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3235072 0.89 ALDH1A1 (0.50) ALDH1A1L3MBTL1SCN9ANOTUMSLC6A2
SCHEMBL3227991 0.88 ALDH1A1 (0.47) ALDH1A1L3MBTL1SCN9AHTR3EHTR3B
SCHEMBL3479627 0.87 ALDH1A1 (0.39) ALDH1A1L3MBTL1SCN9ASLC6A2SLC6A4
SCHEMBL3479763 0.87 GAA (0.47) ALDH1A1L3MBTL1SCN9AHTR3AHRH4
SCHEMBL3238745 0.87 ALDH1A1 (0.48) ALDH1A1L3MBTL1SCN9AHTR3EHTR3B
SCHEMBL3229539 0.85 MAOA (0.43) ALDH1A1L3MBTL1SCN9AHTR3EHTR3B
SCHEMBL3479580 0.85 SCN9A (0.48) ALDH1A1L3MBTL1SCN9AHTR3ANOTUM
SCHEMBL3479793 0.85 DRD1 (0.46) L3MBTL1SLC6A2SLC6A4SLC6A3DRD2
SCHEMBL3218294 0.84 ALDH1A1 (0.46) ALDH1A1L3MBTL1SCN9AHRH4SMN1; SMN2
SCHEMBL3479611 0.84 ALDH1A1 (0.46) ALDH1A1L3MBTL1SCN9AHTR3EHTR3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D ALDH1A1 372/4885L3MBTL1 2286/4885SCN9A 795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.